These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12225249)

  • 1. Investigational pharmacologic treatment for liver disease.
    Siatkosky LL; Shermock KM; Younossi ZM
    Expert Opin Investig Drugs; 2002 Sep; 11(9):1281-93. PubMed ID: 12225249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telbivudine/Torcitabine Idenix/Novartis.
    Hodge RA
    Curr Opin Investig Drugs; 2004 Feb; 5(2):232-41. PubMed ID: 15043399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyminox Biosyn.
    Witherell GW
    Curr Opin Investig Drugs; 2004 Feb; 5(2):222-31. PubMed ID: 15043398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMC-125 Tibotec.
    Haslinger BA; Arendt G
    Curr Opin Investig Drugs; 2004 Feb; 5(2):208-13. PubMed ID: 15043396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology evaluation: cantuzumab mertansine, ImmunoGen.
    Smith SV
    Curr Opin Mol Ther; 2004 Dec; 6(6):666-74. PubMed ID: 15663331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDSVAX VaxGen.
    Billich A
    Curr Opin Investig Drugs; 2004 Feb; 5(2):214-21. PubMed ID: 15043397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofarabine. Bioenvision/ILEX.
    Sternberg A
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1479-87. PubMed ID: 14763136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CKD-602. Chong Kun Dang.
    Crul M
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1455-9. PubMed ID: 14763132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMS-247550 Bristol-Myers Squibb/GBF.
    Lin N; Brakora K; Seiden M
    Curr Opin Investig Drugs; 2003 Jun; 4(6):746-56. PubMed ID: 12901236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lapatinib ditosylate GlaxoSmithKline.
    Kim TE; Murren JR
    IDrugs; 2003 Sep; 6(9):886-93. PubMed ID: 12964069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMT-3. CollaGenex.
    Fingleton B
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1460-7. PubMed ID: 14763133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arzoxifene Eli Lilly.
    Marchisano-Karpman C; DeGregorio MW
    IDrugs; 2003 Sep; 6(9):880-5. PubMed ID: 12964068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 109881 Aventis.
    Ojima I; Geney R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):737-40. PubMed ID: 12901234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEN-10755. Menarini.
    Jones K
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1473-8. PubMed ID: 14763135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZD-6474. AstraZeneca.
    Bates D
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1468-72. PubMed ID: 14763134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganstigmine. Chiesi.
    Johnson A
    Curr Opin Investig Drugs; 2003 Jul; 4(7):868-73. PubMed ID: 14619410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nemifitide. Innapharma.
    Dingemanse J
    Curr Opin Investig Drugs; 2003 Jul; 4(7):859-62. PubMed ID: 14619408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lerisetron. FAES.
    Huckle R
    Curr Opin Investig Drugs; 2003 Jul; 4(7):874-7. PubMed ID: 14619411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLV-308. Solvay.
    Wolf WA
    Curr Opin Investig Drugs; 2003 Jul; 4(7):878-82. PubMed ID: 14619412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology evaluation: TNFerade, GenVec.
    Kircheis R; Wagner E
    Curr Opin Mol Ther; 2003 Aug; 5(4):437-47. PubMed ID: 14513689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.